Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major

There are few papers on the combination therapy of deferiprone (DFP) and deferasirox (DFX) in iron-overloaded patients with transfusion-dependent β-thalassemia major (β-TM). A total of 6 patients with β-TM (5 males and 1 female) with a mean age of 23.8±5.8 years (ranging from 17 to 31) used this tre...

Full description

Bibliographic Details
Main Authors: Hossein Karami, Mehrnoush Kosaryan, Arash Hadian Amree, Hadi Darvishi-Khezri, Masoomeh Mousavi
Format: Article
Language:English
Published: MDPI AG 2017-01-01
Series:Clinics and Practice
Subjects:
Deferiprone
deferasirox
iron overload
?-thalassemia major
MRI T2*.
Online Access:https://www.clinicsandpractice.org/index.php/cp/article/view/912

Internet

https://www.clinicsandpractice.org/index.php/cp/article/view/912

Similar Items